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~onoc~onal antibodies to rat brain choline acetyltransferase were produced by the hybridoma technique. 
Two stable cell lines, Ab-57 and Ab-60, secreted immunoglobulin of subclass IgGl. The monocional 
antibodies bound to choline acetyltransferase without blocking catalytic activity. Affinity of Ab-57 was 
IOO-times higher than that of Ab-60. Both antibodies bound to the rat enzyme in a mutually exclusive 





Choline acetyltransferase (ChAT, acetyl- 
CoA: choline O-acetyltransferase, EC 2.3.1.6) is 
the enzyme responsible for the biosynthesis of the 
neurotransmitter acetylcholine (ACh). This en- 
zyme is currently the most reliable marker for 
cholinergic neurons. The antibody to the enzyme 
would offer a useful method to demonstrate 
cholinergic neurons immunohistochemically and 
to study the biochemical regulation of cholinergic 
activity. Although a number of attempts have been 
made to purify ChAT from mammalian brains and 
to generate a specific antiserum to the enzyme, the 
specificity of the antiserum has been criticized due 
to the impurity of the enzyme preparations used as 
antigens [1,2]. Two laboratories have purified 
ChAT from bovine and porcine brains to a high 
degree and produced the antisera against the en- 
zymes [3-S]. However, the cross-reactivity of the 
ant.ibodies to ChAT from other mammalian brains 
and the usefulness for immunohistochemical nd 
biochemic~ studies have not been evaluated yet. 
An alternative method for producing the 
monospecific antibodies is the newly developed 
monoclonal antibody technology [6], which allows 
the use of a partially purified enzyme as an an- 
tigen. The monoclonal antibody would be also 
Cross-species reactivity ~hol~~ergic neuron 
useful for studying the different properties of en- 
zyme molecules among various species. We report 
here the production and characterization of the 
monoclonal antibodies to ChAT purified from rat 
brain. 
2, MATERIALS AND METHODS 
2.1. Purification of ChAT 
ChAT was purified from rat brain (300-350 g) 
as in [7] with the modifications that acetone 
powder of the tissue was used as a starting material 
[8] and that blue dextran-Sepharose was used in- 
stead of CoA-Sepharose [4]. The procedure in- 
cluded homogenization and solubilization of 
acetone powder, acid precipitation at pH 4.5, 
(NH&SOJ fractionation and CM-Sephadex, blue 
dextran-Sepharose and hydroxylapatite column 
chromatographies equentially. The specific ac- 
tivities of the enzyme preparations from different 
batches of rat brain were - 10,umol ACh form- 
ed.min-‘. mg protein- I. 
2.2. Production of monoclonal antibodies 
A BALB/c mouse was injected intraperitoneally 
with 243 pg purified ChAT with 1.5 x 10’ heat- 
inactivated pertussis vaccine. The animal received 
a booster (96 pug ChAT) without pertussis vaccine 
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intraperitoneally 21 days after the first immuniza- 
tion. The animal was sacrificed 3 days after the 
booster and spleen cells (4 x lo*) were fused with 
mouse myeloma cells P3-NS I/l-Ag4-1 (1.5 x lo*) 
by the addition of 2 ml 50% polyethylene glycol 
4000. The cells were suspended in HAT selective 
medium (RPM1 1640 medium supplemented with 
15% fetal calf serum, 2 mM L-glutamine, 1 mM 
pyruvate, 100 PM hypoxanthine, 0.4 pM 
aminopterin and 16 PM thymidine), and in- 
oculated into eight 96-well microtest plates (5 x lo5 
spleen cells/well); 4 and 6 days after the cell fu- 
sion, 50~1 of HAT medium was added. Cultures 
showing hybrid growth were screened for produc- 
tion of anti-ChAT antibodies as described below. 
Positive cells were cloned by a limiting dilution 
method 4 times. 
2.3. Purification of antibodies 
Ascites tumors were induced by injecting 1 x 10’ 
hybridoma cells into Pristane-primed BALB/c 
mice intraperitoneally. Antibody was purified by a 
pH stepwise gradient elution after adsorption to a 
protein A-Sepharose column (1 cm x 6 cm) [9]. 
2.4. Detection of anti-ChAT antibodies 
For the detection of antibody, ChAT was par- 
tially purified from acetone powder of rat brain up 
to pH 4.5 precipitation. ChAT preparation 
(-0.3 nmol/min) was incubated with 50 ~1 culture 
fluid for 1 h at 20°C in 100~1 total vol. Then, 
20~1 rabbit anti-mouse IgG serum coupled to 
formalin-fixed Staphylococcus aureus (lo%, v/v) 
was added and incubated for an additional 1 h at 
20°C. The enzyme-antibody complex was remov- 
ed by centrifugation, and the supernatant was 
assayed for ChAT activity as in [lo]. Formation of 
the enzyme-antibody complex did not differ bet- 
ween the incubation at 20°C for 2 h and the in- 
cubation at 4°C overnight. 
2.5. Scatchard plot analysis of antibody titration 
curve 
An estimated activity of 100 pmol . min-’ . mg 
protein-’ [ll] and Mr 68000 [12] for rat ChAT 
were used to calculate the quantities of ChAT 
bound to various amounts of antibody. Antibody 
titration curves were analyzed by the method of 
Scatchard [ 131 using a linear least squares curve- 
fitting routine. 
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Fig.1. Titration of rat ChAT with monoclonal 
antibodies. Rat ChAT preparation was incubated with 
were the means of duplicate determinations. 
Ab-57 (A) or Ab-60 (B) as indicated and ChAT activity 
remaining in the supernatant (0) was assayed as in 
section 2. As a negative control (A), monoclonal 
antibody to hemagglutinin of influenza virus (PR-8 
strain) was used. In another series of experiments, ChAT 
activity was assayed without addition of anti-mouse IgG 
coupled to S. aureus and centrifugation (0). The values 
2.6. Analysis of immune complexes 
Interaction of the antibodies with ChAT was 
analyzed with velocity sedimentation of immune 
complexes. Rat ChAT preparations 
(-0.8 nmol/min) were incubated with Ab-57 
(2.4 pg) or Ab-60 (22 pg), or both in 235 ~1 total 
vol. In a control tube, the antibodies were omitted. 
Incubation was carried out for 1 h at 20°C and for 
4 h at 4°C. Samples were layered over 5-20070 
sucrose density gradients in phosphate buffered 
saline (pH 7.4), and centrifuged at 86000 x g for 
14 h at 4°C. The samples were fractionated into 19 
aliquots which were analyzed for ChAT activity. 
Standard proteins were treated in an identical man- 
ner and detected with absorbance at 280 nm. 
3. RESULTS 
After 2 weeks of selection in HAT medium, 66% 
of the wells contained growing hybridomas. Out of 
4 wells initially positive for anti-ChAT activity on- 
ly two wells survived repetitive cloning. Two cell 
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lines, Ab-57 and Ab-60, were established after 4 
cloning operations. Both cell lines secreted im- 
munoglobulin of subclass IgG 1, because both anti- 
bodies were eluted at pH 6.0 from a protein 
A-Sepharose column. Ab-57 and Ab-60 produced 
ascites fluids containing 1.6 mg and 100 ,ug anti- 
body/ml, respectively. Purified antibodies from 
ascites fluids were used in the following 
experiments. 
Titration of rat ChAT by the antibodies was 
shown in fig.1: 50% inhibition was observed with 
5 ng Ab-57 and 500 ng Ab-60, respectively. When 
ChAT preparation was incubated with antibody 
alone, all the enzyme activity was recovered in the 
supernatant. ChAT activity in the supernatant 
decreased only when the enzyme-antibody com- 
plex was removed by precipitation with anti-mouse 
IgG coupled to S. aureus. ChAT activity was 
recovered in the precipitate, although the forma- 
Moles Antlbody (x10-=) 
“l)tt. Antlbodg f x10-“) 
Fig.2 Titration curves and Scatchard plots of rat ChAT 
with Ab-57 (A) and Ab-60 (B). Procedure and assays 
were performed as in section 2. The values were the 
means of duplicate determinations. 
tion of the enzyme-antibody-anti-mouse IgG-S. 
aureus complex decreased the enzyme activity to 
the half of the expected value. Control incubation 
using anti-hemaggIutinin of in~ue~a virus did not 
inhibit ChAT activity. These results indicated that 
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Fig.3. Effects of monoclonal antibodies on velocity 
sedimentation of rat ChAT. Rat ChAT preparations 
were incubated without (A) or with Ab-57 (B), Ab-60 (C) 
and Ab-57 pius Ab-60 (D). S values indicated were 
obtained by the sedimentation of bovine serum albumin 
(4.4 S), bovine ~-globulin (7.3 S) and cataiase (11.2 S). 
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Table 1 
Cross-reactivity of monoclonal antibodies with ChAT from brains of various vertebrates 
Species No addition Ab-57 (10 ng) Ab-57 (1 ag) Ab-60 (1 pg) 
ChAT ChAT % activity ChAT %I activity ChAT VII activity 
activity activity of no activity of no activity of no 
(pmol/min) (pmol/min) addition (pmol/min) addition (pmoI/min) addition 
Rat 151 22 15 10 6 22 14 
Mouse 133 37 28 12 9 42 32 
Guinea pig 103 100 97 55 53 114 111 
Cat 81 27 34 2 3 39 48 
Monkey 122 114 94 21 18 112 91 
Chicken 144 116 81 118 82 117 81 
Turtle 103 100 97 98 95 101 99 
Frog 33 32 98 23 70 34 102 
Carp 128 116 91 119 93 120 93 
ChAT preparations of various species were prepared in a similar manner to rat ChAT preparation and incubated with 
monoclonal antibodies as indicated for 1 h at 20°C. ChAT activity remaining in the supernatant was assayed as in 
section 2. The values were the means of duplicate determinations 
both antibodies reacted with the enzyme without 
blocking the catalytic site. 
Affinity of each antibody for rat ChAT was 
calculated from titration curves and Scatchard 
plots (fig.2) assuming spec. act. 
100 pmol. min-’ . mg protein-’ and Mr 68000 for 
rat ChAT. Scatchard plots were linear indicating 
that each antibody recognized a single binding site. 
Affinity (&) was calculated to be 3.81 x lo9 M-’ 
for Ab-57 and 1.91 x IO7 M-’ for Ab-60, 
respectively. 
The effect of antibodies on the sedimentation 
profile of rat ChAT activity was shown in fig.3. 
An identical shift in sedimentation pattern was 
observed when ChAT was incubated with either 
Ab-57 or Ab-60, or both. This indicated that both 
antibodies bound to rat ChAT in a mutually ex- 
clusive fashion. ChAT activity of the 
enzyme-antibody complex decreased to the half of 
that of the enzyme alone. 
Cross-reactivity of both antibodies with various 
mammalian brain ChAT was shown in table 1. 
Both Ab-57 and Ab-60 antibodies cross-reacted 
with ChAT from mouse and cat with affinities 
similar to rat ChAT. A high dose of Ab-57 (1 pg) 
showed partial reactivity with ChAT from guinea 
pig and monkey. Both antibodies showed no or 
marginal cross-reactivity with ChAT from non- 
mammalian species. 
4, DISCUSSION 
This paper reports the establishment and 
characterization of the monoclonal antibodies to 
ChAT from rat brain. During this investigation, 
several reports have appeared ealing with the pro- 
duction of monoclonal antibodies to ChAT from 
rat [14,15], bovine [16], porcine [5] and 
Drosophila [ 171. Two antibodies established here 
seem to bind to neighboring regions of the enzyme 
surface and have a similar cross-species reactivity 
with mammalian enzymes. However, both anti- 
bodies have different affinities. A remarkably high 
affinity of Ab-57 with an order of lo9 M-’ would 
be a useful feature for the quantification of ChAT 
molecule to study the kinetics and regulatory 
mechanisms of ACh synthesis, However, a 
moderate affinity of Ab-60 with an order of 
lo7 M-l may offer a suitable ligand to prepare im- 
munoaffinity chromatography. Cross-species reac- 
tivity of both antibodies with mammalian ChAT 
offers a tool for biochemical and im- 
munohistochemical studies of cholinergic neurons 
in various mammalian brains. Several antibodies 
to bovine ChAT have cross-species reactivity with 
mammalian ChAT [ 161. Using the antibodies ob- 
tained here, we are trying to im- 
munohistochemically demonstrate the cholinergic 
neurons in mammalian brains. 
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